Yr Athro Philip Routledge

2016

• Deslandes, P.et al. 2016. A change in the trend in dosulepin usage following the introduction of a prescribing indicator but not after two national safety warnings. Journal of Clinical Pharmacy and Therapeutics 41(2), pp. 224-228. (10.1111/jcpt.12376)

2013

• Routledge, P. A. and Hutchings, A. 2013. Therapeutic drug monitoring (TDM). In: Wild, D. ed. The immunoassay handbook : Theory and Applications of Ligand Binding, ELISA and Related Techniques. Oxford: Elsevier, pp. 945-962., (10.1016/B978-0-08-097037-0.00076-2)

2012

• Routledge, P. A. 2012. Safe prescribing: A titanic challenge. British Journal Of Clinical Pharmacology 74(4), pp. 676-684. (10.1111/j.1365-2125.2012.04367.x)
• Routledge, P. A. 2012. A national in-patient prescription chart: the experience in Wales 2004-2012. British Journal of Clinical Pharmacology 74(4), pp. 561-565. (10.1111/j.1365-2125.2012.04283.x)
• Veiraiah, A.et al. 2012. Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data. Emergency Medicine Journal 29(7), pp. 565-569. (10.1136/emj.2010.095075)
• Shetty, H. . G. M. and Routledge, P. A. 2012. Anticoagulants. In: Sinclair, A. J., Morley, J. E. and Vellas, B. eds. Pathy's Principles and Practice of Geriatric Medicine., Vol. 1 & 2. Oxford: John Wiley & Sons, pp. 357-362., (10.1002/9781119952930.ch31)

2011

• Park, B. K.et al. 2011. Managing the challenge of chemically reactive metabolites in drug development. Nature Reviews Drug Discovery 10(4), pp. 292-306. (10.1038/nrd3408)
• Damery, S. L.et al. 2011. The use of herbal medicines by people with cancer: a cross-sectional survey. British Journal of Cancer 104(6), pp. 927-933. (10.1038/bjc.2011.47)

2010

• Cohen, D.et al. 2010. Abolition of prescription co-payments in Wales: an observational study on dispensing rates [Abstract]. Journal of Epidemiology and Community Health 64, pp. A25-A25. (10.1136/jech.2010.120956.62)
• Veiraiah, A.et al. 2010. Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data [Abstract]. Clinical Toxicology 48(6), pp. 648. (10.3109/15563650.2010.493290)
• Cohen, D.et al. 2010. Abolition of prescription copayments in Wales: an observational study on dispensing rates. Value In Health 13(5), pp. 675-680. (10.1111/j.1524-4733.2010.00717.x)
• Groves, S.et al. 2010. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay. International Journal of Pharmacy Practice 18(6), pp. 332-340. (10.1111/j.2042-7174.2010.00063.x)
• Shetty, H. G. M., Campbell, I. A. and Routledge, P. A. 2010. Venous thromboembolism in the elderly. In: Fillit, H. M., Rockwood, K. and Woodhouse, K. eds. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 7th ed.. Philadelphia, PA: Elsevier, pp. 356-361., (10.1016/B978-1-4160-6231-8.10048-0)

2009

• Hughes, D. A.et al. 2009. Impact of the abolition of the prescription charge in Wales [Abstract]. Basic & Clinical Pharmacology & Toxicology 105(S1), pp. 94.
• Ghandforoush-Sattari, M.et al. 2009. A rapid determination of taurine in human plasma by LC. Chromatographia 69(11-12), pp. 1427-1430. (10.1365/s10337-009-1055-6)
• Aronson, J. K.et al. 2009. The UK's NHS and pharma: need for more clinical pharmacologists [Correspondence]. The Lancet 373(9671), pp. 1251-1252. (10.1016/S0140-6736(09)60726-1)
• Gratus, C.et al. 2009. The use of herbal medicines by people with cancer: a qualitative study. BMC Complementary and Alternative Medicine 9(14) (10.1186/1472-6882-9-14)
• Hughes, D. A.et al. 2009. Abolition of prescription co-payments: an analysis of items dispensed in Wales [Abstracts]. Value In Health 12(3), pp. A80. (10.1016/S1098-3015(10)73460-4)
• Mashayekhi, S. O.et al. 2009. Pharmacokinetic and Pharmacodynamic Study of Morphine and Morphine 6-Glucuronide after Oral and Intravenous Administration of Morphine in Children with Cancer. Biopharmaceutics & Drug Disposition 30(3), pp. 99-106. (10.1002/bdd.649)
• Veiraiah, A. and Routledge, P. A. 2009. Adverse effects of anticoagulants. Adverse Drug Reaction Bulletin(258), pp. 991-994.
• Gratus, C.et al. 2009. The use of herbal medicines by people with cancer in the UK: a systematic review of the literature. QJM 102(12), pp. 831-842. (10.1093/qjmed/hcp137)

2008

• Routledge, P. A. 2008. The European herbal medicines directive: could it have saved the lives of Romeo and Juliet?. Drug Safety 31(5), pp. 416-418. (10.2165/00002018-200831050-00006)
• Routledge, P. A. 2008. Antidotes for European viper envenomation [Abstract]. Clinical Toxicology 46(5), pp. 401. (10.1080/15563650802071703)

2007

• Ghandforoush-Sattari, M.et al. 2007. Admissions to the Cardiff Poisons Unit involving paracetamol poisoning (1989-2002). Toxicology Letters 172(S), pp. S229., article number: Z20. (10.1016/j.toxlet.2007.05.577)
• Routledge, P. A.et al. 2007. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. British Medical Journal 334(7595), pp. 674-677. (10.1136/bmj.39098.583356.55)
• Blenkinsopp, A.et al. 2007. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. British Journal Of Clinical Pharmacology 63(2), pp. 148-156. (10.1111/j.1365-2125.2006.02746.x)
• Campbell, I.et al. 2007. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. British Medical Journal (BMJ) 334(7595), pp. 674-677. (10.1136/bmj.39098.583356.55)
• Routledge, P. A., Woodfield, R. and Anderson, L. 2007. Promoting safe use of herbal medicines: A way forward. Toxicology 240(3), pp. 146-147. (10.1016/j.tox.2007.06.030)

2005

• Routledge, P. A.et al. 2005. A distance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. British Journal of Clinical Pharmacology 60(2), pp. 221-223. (10.1111/j.1365-2125.2005.02419.x)

2004

• Ingram, J. R.et al. 2004. Nicotine enemas for treatment of ulcerative colitis: a study of the pharmacokinetics and adverse events associated with three doses of nicotine. Alimentary Pharmacology and Therapeutics 20(8), pp. 859-865. (10.1111/j.1365-2036.2004.02199.x)

2003

• Routledge, P. A.et al. 2003. The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme. British Journal of Clinical Pharmacology 56(6), pp. 658-663. (10.1046/j.1365-2125.2003.01903.x)

2002

• Watson, I.et al. 2002. Laboratory analyses for poisoned patients: joint position paper. Annals of Clinical Biochemistry 39(4), pp. 328-339. (10.1258/000456302760042083)
• Ionescu, A.et al. 2002. Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis. American journal of respiratory and critical care medicine 165(4), pp. 495-500.
• Holme, A.et al. 2002. Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK. QJM: An International Journal of Medicine 95(7), pp. 439-444. (10.1093/qjmed/95.7.439)

2001

• Routledge, P. A.et al. 2001. Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example. British Journal of Clinical Pharmacology 52(5), pp. 573-577. (10.1046/j.0306-5251.2001.01490.x)

2000

• Bowen, H.et al. 2000. Community exposures to chemical incidents: development and evaluation of the first environmental public health surveillance system in Europe. Journal of Epidemiology & Community Health 54(11), pp. 870-873. (10.1136/jech.54.11.870)
• Lyons, R. A.et al. 2000. Investigation of an acute chemical incident: exposure to fluorinated hydrocarbons. Occupational and Environmental Medicine 57(9), pp. 577-581. (10.1136/oem.57.9.577)

1999

• Holgate, S. T.et al. 1999. Summary of the conclusions. Clinical and Experimental Allergy 29(S3), pp. iv-vi. (10.1046/j.1365-2222.1999.00001.x-i1)

1998

• Routledge, P. A.et al. 1998. Letter [Paracetamol (acetaminophen) poisoning - No need to change current guidelines to accident departments] [Correspondence]. British Medical Journal 317(7173), pp. 1609-1610. (10.1136/bmj.317.7173.1609)
• Routledge, P. A.et al. 1998. Case studies in therapeutics: warfarin resistance and inefficacy in a man with recurrent thromboembolism, and anticoagulant-associated priapism [Case report]. British Journal of Clinical Pharmacology 46(4), pp. 343-346. (10.1046/j.1365-2125.1998.t01-1-00796.x)
• Routledge, P. A. 1998. 150 years of pharmacovigilance. The Lancet 351(9110), pp. 1200-1201. (10.1016/S0140-6736(98)03148-1)

1996

• Finlay, I. G.et al. 1996. Jack Kevorkian: a medical hero? Law has a protective function for both patients and doctors [Correspondence]. British Medical Journal 313(7051), pp. 227-228. (10.1136/bmj.313.7051.227c)

1994

• Beck, P.et al. 1994. Increasing rate of deliberate self poisoning [Correspondence]. British Medical Journal 308(6931), pp. 789. (10.1136/bmj.308.6931.789)

1989

• Orme, M.et al. 1989. Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field. British Journal of Clinical Pharmacology 27(2), pp. 125-133.
• Watt, A. H.et al. 1989. Adenosine-induced respiratory and heart rate changes in young and elderly adults. British Journal of Clinical Pharmacology 27(2), pp. 265-267. (10.1111/j.1365-2125.1989.tb05360.x)
• Bayer, A. J.et al. 1989. The pharmacokinetics of paroxetine in the elderly. Acta Psychiatrica Scandinavica Supplementum 80(S350), pp. 85-86. (10.1111/j.1600-0447.1989.tb07179.x)

1988

• Phillips, D.et al. 1988. The effect of thyroid status on isoniazid acetylation. Presented at: International Thyroid Symposium 1988, Tokyo, Japan, 13-15 July 1988 Presented at Nagataki, S. and Torizuka., K. eds.The Thyroid, 1988: Proceedings of the International Thyroid Symposium, Tokyo, 13-15 July 1988. International congress series Vol. 796. Amsterdam: Excerpta Medica pp. 419-422.
• Buss, D. C.et al. 1988. The effects of aminophylline on thyrotoxic tremor. Presented at: International Thyroid Symposium 1988, Tokyo, Japan, 13-15 July 1988 Presented at Nagataki, S. and Torizuka, K. eds.The Thyroid, 1988: Proceedings of the International Thyroid Symposium, Tokyo, 13-15 July 1988. International congress series Vol. 796. Amsterdam: Excerpta Medica pp. 455-458.

1987

• Fennerty, A.et al. 1987. Presenting features of patients with pulmonary emboli [Abstract]. Thorax 42(3), pp. 229. (10.1136/thx.42.3.207)
• Littley, M.et al. 1987. Effect of thyroid status on hepatic drug-metabolism [Abstract]. Clinical Science 72(S16), pp. 41P. (10.1042/cs072041Pb)

1986

• Watt, A. H.et al. 1986. Angina pectoris-like pains provoked by intravenous adenosine [Correspondence]. British Medical Journal 293(6545), pp. 504-505. (10.1136/bmj.293.6545.504-a)

1984

• Routledge, P. A. 1984. Who needs clinical pharmacology? [Correspondence]. British Medical Journal 289(6456), pp. 1451. (10.1136/bmj.289.6456.1451-b)

1982

• Palva, E. S.et al. 1982. Actions and interactions of diazepam and alcohol on psychomotor skills in young and middle-aged subjects. Acta Pharmacologica et Toxicologica 50(5), pp. 363-369. (10.1111/j.1600-0773.1982.tb00988.x)

1976

• Marks, J.et al. 1976. Stathmokenetic action of vincristine in psoriatic epidermis [Abstract]. Journal of Investigative Dermatology 66(4), pp. 260-261. (10.1111/1523-1747.ep12482197)